Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,517 | -24,786 | -10,137 | -30,108 | -24,679 |
| Depreciation Amortization | 466 | 317 | 163 | 743 | 576 |
| Accounts receivable | -1,123 | 1,218 | -1,165 | 2,447 | 2,193 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -2,049 | N/A |
| Other Working Capital | 2,572 | -71 | -2,121 | 3,808 | 1,824 |
| Other Operating Activity | 6,941 | 7,261 | 4,301 | -1,371 | -1,929 |
| Operating Cash Flow | $-24,661 | $-16,061 | $-8,959 | $-26,530 | $-22,015 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,148 | 8,249 | -1,017 | -3,644 | -1,387 |
| PPE Investments | -41 | -7 | -7 | 20 | 24 |
| Other Investing Activity | 1 | 1 | 1 | 157 | 158 |
| Investing Cash Flow | $13,108 | $8,243 | $-1,023 | $-3,467 | $-1,205 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 111,546 | 110,873 | 3,932 | 25,090 | 25,089 |
| Other Financing Activity | 0 | -2,700 | -1,530 | 5,180 | 3,290 |
| Financing Cash Flow | $111,546 | $108,173 | $2,402 | $30,270 | $28,379 |
| Beginning Cash Position | 21,164 | 21,164 | 21,164 | 20,891 | 20,891 |
| End Cash Position | 121,157 | 121,519 | 13,584 | 21,164 | 26,050 |
| Net Cash Flow | $99,993 | $100,355 | $-7,580 | $273 | $5,159 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,661 | -16,061 | -8,959 | -26,530 | -22,015 |
| Capital Expenditure | -41 | -7 | -7 | -30 | -26 |
| Free Cash Flow | -24,702 | -16,068 | -8,966 | -26,560 | -22,041 |